Table 1.
Study | Primary stage | CEA level | Size of major metastasis | Number liver metastases | Disease free interval | Extrahepatic disease | Surgical margins |
Scheele et al[11] | P | NA | P | NP | P | P | P |
Nordlinger et al[10] | P | P | P | P | P | NA | P |
Fong et al[9] | P | P | P | P | P | P | P |
Mann et al[12] | P | P | P | NP | NP | NA | NA |
Rees et al[15] | P | P | P | P | NA | P | P |
John et al[21] | NP | P | NP | NP | NA | NP | P |
Doci et al[27] | P | NP | NP | NP | NP | NA | NA |
Hughes et al[34] | P | P | P | P | P | NA | NA |
Gayowski et al[37] | P | NA | NP | P | NP | P | P |
CEA: Carcinoembryonic antigen; P: Prognostic; NP: Non prognostic; NA: Non available.